Get the Stockscreener App
2.095
0.24%
0.005
After Hours:
2.08
-0.015
-0.72%
Qualigen Therapeutics Inc stock is traded at $2.095, with a volume of 24,867.
It is up +0.24% in the last 24 hours and up +24.70% over the past month.
Qualigen Therapeutics Inc is an early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's program, QN-302, is an investigational small-molecule G-quadruplexes (G4)-selective transcription inhibitor with binding affinity to G4s prevalent in cancer cells.
See More
Previous Close:
$2.09
Open:
$2.06
24h Volume:
24,867
Relative Volume:
0.03
Market Cap:
$3.55M
Revenue:
$4.79M
Net Income/Loss:
$-13.42M
P/E Ratio:
-0.7876
EPS:
-2.66
Net Cash Flow:
$-10.30M
1W Performance:
+23.96%
1M Performance:
+24.70%
6M Performance:
-30.40%
1Y Performance:
-74.25%
1-Day Range:
$2.00
$2.12
1-Week Range:
$1.69
$2.1594
52-Week Range:
$1.61
$10.45
Qualigen Therapeutics Inc Stock (QLGN) Company Profile
Name
Qualigen Therapeutics Inc
Sector
Industry
Phone
(760) 918-9165
Address
2042 CORTE DEL NOGAL, CALIFORNIA
Compare QLGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QLGN
Qualigen Therapeutics Inc
|
2.095 | 3.15M | 4.79M | -13.42M | -10.30M | -2.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Qualigen Therapeutics Inc Stock (QLGN) Latest News
Will Qualigen Therapeutics Inc. stock go up soonJuly 2025 Volume & Community Consensus Picks - Newser
Real time breakdown of Qualigen Therapeutics Inc. stock performanceSwing Trade & Reliable Intraday Trade Alerts - Newser
Reversal indicators forming on Qualigen Therapeutics Inc. stockEarnings Recap Report & Low Risk High Win Rate Stock Picks - Newser
Does Qualigen Therapeutics Inc. qualify in momentum factor screeningProduct Launch & Weekly High Conviction Ideas - Newser
Key resistance and support levels for Qualigen Therapeutics Inc.2025 Price Momentum & Advanced Technical Signal Analysis - Newser
Market reaction to Qualigen Therapeutics Inc.’s recent newsTrade Analysis Summary & Scalable Portfolio Growth Ideas - Newser
Will earnings trigger a reversal in Qualigen Therapeutics Inc.Bear Alert & Safe Capital Growth Tips - Newser
Order flow analysis tools used on Qualigen Therapeutics Inc.July 2025 Highlights & Growth Oriented Trade Recommendations - Newser
Qualigen Therapeutics Inc. stock momentum explainedBreakout Watch & Real-Time Buy Signal Alerts - Newser
Combining price and volume data for Qualigen Therapeutics Inc.Weekly Market Summary & Expert Approved Momentum Ideas - Newser
Published on: 2025-09-11 19:14:24 - Newser
Published on: 2025-09-11 18:51:51 - Newser
Using data filters to optimize entry into Qualigen Therapeutics Inc.July 2025 Reactions & Long-Term Growth Plans - Newser
will qualigen therapeutics inc. stock go up soonWeekly Stock Recap & Growth Focused Entry Reports - Newser
Published on: 2025-09-10 04:11:58 - Newser
What candlestick patterns are forming on Qualigen Therapeutics Inc.Quarterly Trade Review & Accurate Technical Buy Alerts - Newser
does qualigen therapeutics inc. qualify in momentum factor screeningTrade Exit Report & Weekly High Conviction Trade Ideas - Newser
Qualigen Therapeutics Granted Nasdaq Compliance Extension - MSN
real time alert setup for qualigen therapeutics inc. performance2025 Year in Review & Fast Moving Stock Trade Plans - Newser
Strategies to average down on Qualigen Therapeutics Inc.2025 Earnings Impact & Real-Time Volume Surge Alerts - Newser
Chart based analysis of Qualigen Therapeutics Inc. trendsInsider Selling & Verified Swing Trading Watchlist - Newser
Qualigen Therapeutics Inc Stock (QLGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):